Gesamtlänge aller Episoden: 11 days 12 hours 51 minutes
Novel Therapies for Patients With DLBCL: What Does the Future Hold?
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
Evaluating the Evidence for SGLT2 Inhibition in CKD
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
Wake Up and Smell the Coffee: Kicking Into Play Novel Treatment Options for Nasal Polyposis
The Evolving Role of AR-Targeted Agents in Prostate Cancer: A Window of Opportunity to Maximize Outcomes
A Look at Emerging SMA Outcomes: Highlights of CureSMA 2020
A Look at Emerging SMA Outcomes: Highlights of EAN 2020
Updated Strategies for Improving Assessment, Diagnosis, and Referral of Patients With Fabry Disease
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs